Accenture’s recent rally of 3.5% contrasts with a volatile year that sees the consultancy trading significantly below its estimated intrinsic value, highlighting contrasting sentiments among investors and insiders alike.
Accenture’s shares rose 3.5% to $183.37 on 30 September 2026, but the rebound came against a rougher backdrop: the stock has swung between $118.15 and $291.09 over the past year and remains sharply lower than where it began 2026. GuruFocus said the move left the consultancy trading well below its estimated GF Value, with the shares priced about 49% under that measure, even after the day’s gain.
That gap is what keeps some investors interested. GuruFocus put Accenture’s GF Score at 87 out of 100, a reading that reflects strong marks for profitability and growth even as valuation and momentum lag. The platform also pointed to a forward price-to-earnings ratio of 12.6 times and a trailing multiple of 14.6 times, both below the company’s five-year median. Taken together, those figures suggest a stock that looks inexpensive by historical standards, even if the market has not yet rewarded that view.
The latest data also show a mixed message from sophisticated investors. GuruFocus said 18 prominent investors still hold Accenture shares, with more adding to positions than trimming them in recent quarters. At the same time, company insiders have sold $18.7 million worth of stock over the past 12 months and have not been buyers, a pattern that can be interpreted in several ways, from routine portfolio management to caution about the near term.
Accenture’s recent trading has been volatile enough to keep valuation arguments from settling the debate on their own. On 18 September, GuruFocus reported that the shares fell 4.7% to $181.29 and were down 30.6% for the year to date, while on 11 September they had risen 3.4% to $183.90, still sitting below the same intrinsic value estimate. Earlier in August, the stock traded at $169.98 with an even steeper implied discount. The sequence suggests a company whose fundamentals may still appeal to value investors, but whose share price has yet to stabilise around that case.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
